Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 4/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.45 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.45 |
| ▸ | KLK7 | P49862 | 2/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.43 |
| ▸ | CPB1 | P15086 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22750141 | 0.95 | FOLH1 (0.49) | SIRT2SIRT1KLK7KLK5FOLH1 | |
| SCHEMBL22750286 | 0.91 | SIRT2 (0.47) | SIRT2SIRT1SIRT3KLK7KLK5 | |
| SCHEMBL29454943 | 0.91 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CPB1CPB2 | |
| SCHEMBL29454929 | 0.91 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CPB1CPB2 | |
| SCHEMBL29454928 | 0.91 | SIRT2 (0.49) | SIRT2SIRT1SIRT3CPB1CPB2 | |
| SCHEMBL30391867 | 0.89 | LMNA (0.43) | — | |
| SCHEMBL29454921 | 0.89 | SIRT2 (0.48) | SIRT2SIRT1SIRT3FOLH1CPB1 | |
| SCHEMBL30891420 | 0.89 | SIRT2 (0.47) | SIRT2SIRT1SIRT3FOLH1CPB1 | |
| SCHEMBL30391887 | 0.84 | MMP13 (0.45) | SIRT2FOLH1 | |
| SCHEMBL23519413 | 0.84 | FOLH1 (0.44) | FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020247297-A1 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2020-12-10 | — | — | WO | disclosed |